Molnupiravir

Overview

Molnupiravir (EIDD-2801) is an orally bioavailable proagent of the ribonucleoside analog EIDD-1931. Molnupiravir has broad spectrum antiviral activity against influenza virus and multiple coronaviruses , such as SARS-CoV-2 , MERS-CoV , SARS-CoV . Molnupiravir has the potential for the research of COVID-19, and seasonal and pandemic influenza.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Viral Infection | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > SARS-CoV | Products > Signaling Pathways > Influenza Virus

Product Information

• Catalog No.: HY-135853
• CAS No.: 2492423-29-5
• Molecular Formula: C13H19N3O7
• Molecular Weight: 329.31
• Purity: 99.85%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (7.59 mM); Clear solution
• Availability: In-stock

Source

Original product source